Phagemid-based capsid system for CRISPR-Cas13a antimicrobials targeting methicillin-resistant Staphylococcus aureus
-
Published:2024-09-13
Issue:1
Volume:7
Page:
-
ISSN:2399-3642
-
Container-title:Communications Biology
-
language:en
-
Short-container-title:Commun Biol
Author:
Li Feng-Yu, Tan Xin-Ee, Shimamori Yuzuki, Kiga KotaroORCID, Veeranarayanan Srivani, Watanabe ShinyaORCID, Nishikawa Yutaro, Aiba Yoshifumi, Sato’o Yusuke, Miyanaga Kazuhiko, Sasahara Teppei, Hossain Sarah, Thitiananpakorn Kanate, Kawaguchi Tomofumi, Nguyen Huong MinhORCID, Yeo Syin Lian Adeline, Sultana Sharmin, Alessa Ola, Kumwenda Geoffrey, Sarangi Jayathilake, Revilleza Jastin Edrian Cocuangco, Baranwal Priyanka, Faruk Mohammad Omar, Hidaka Yuya, Thu Myat, Arbaah Mahmoud, Batbold Anujin, Maniruzzaman , Liu Yi, Duyen Ho Thi My, Sugano Takashi, Tergel Nayanjin, Shimojyo Takayuki, Cui LongzhuORCID
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. O’Neill, J. Tackling drug-resistant infections globally: Final report and recommendations. Rev. Antimicrob. Resist. (2016). 2. CDC. Antibiotic resistance spreads across the world. Centers Dis. Control Prev. (2022). 3. Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. P T 40, 277–283 (2015). 4. Anderson, M., Schulze, K., Cassini, A., Plachouras, D. & Mossialos, E. A governance framework for development and assessment of national action plans on antimicrobial resistance. Lancet Infect. Dis. 19, e371–e384 (2019). 5. Dublanchet, A. & Fruciano, E. A short history of phage therapy. Med. Mal. Infect. 38, 415–420 (2008).
|
|